Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting No phase listed Observational

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

ClinicalTrials.gov ID: NCT05775523

Public ClinicalTrials.gov record NCT05775523. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Non-interventional (NIS), Long-term, Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

Study identification

NCT ID
NCT05775523
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Ascendis Pharma Endocrinology Division A/S
Industry
Enrollment
500 participants

Conditions and interventions

Interventions

  • No intervention Drug

Drug

Eligibility (public fields only)

Age range
1 Year to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 19, 2023
Primary completion
Feb 28, 2033
Completion
Feb 28, 2033
Last update posted
Feb 3, 2026

2023 – 2033

United States locations

U.S. sites
27
U.S. states
21
U.S. cities
26
Facility City State ZIP Site status
Ascendis Investigational Site Phoenix Arizona 85054 Recruiting
Ascendis Investigational Site Orange California 92868 Recruiting
Ascendis Investigational Site Sacramento California 95821 Recruiting
Ascendis Investigational Site San Francisco California 94143 Recruiting
Ascendis Pharma Investigational Site Centennial Colorado 80112 Recruiting
Ascendis Investigational Site Washington D.C. District of Columbia 20010 Recruiting
Ascendis Investigational Site Orlando Florida 32806 Recruiting
Ascendis Investigational Site Orlando Florida 32827 Recruiting
Ascendis Investigational Site Tampa Florida 33612 Recruiting
Ascendis Investigational Site Sandy Springs Georgia 30350 Recruiting
Ascendis Investigational Site Boise Idaho 83712 Recruiting
Ascendis Investigational Site Indianapolis Indiana 46202 Recruiting
Ascendis Investigational Site Iowa City Iowa 52242 Recruiting
Ascendis Investigational Site Louisville Kentucky 40202 Recruiting
Ascendis Investigational Site Minneapolis Minnesota 55455 Recruiting
Ascendis Investigational Site Las Vegas Nevada 89113 Recruiting
Ascendis Investigational Site Lebanon New Hampshire 03756 Recruiting
Ascendis Investigational Site Manchester New Hampshire 03104 Recruiting
Ascendis Investigational Site Morristown New Jersey 07960 Recruiting
Ascendis Investigational Site New Hyde Park New York 11042 Recruiting
Ascendis Investigational Site Cincinnati Ohio 45229 Recruiting
Ascendis Investigational Site Portland Oregon 97239 Recruiting
Ascendis Investigational Site Columbia South Carolina 29203 Recruiting
Ascendis Investigational Site Dallas Texas 75390 Recruiting
Ascendis Investigational Site El Paso Texas 79907 Recruiting
Ascendis Investigational Site Norfolk Virginia 23507 Recruiting
Ascendis Investigational Site Seattle Washington 98105 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05775523, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05775523 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →